TY - JOUR AU - Warkentin, T. E. AU - Greinacher, A. PY - 2004 DA - 2004// TI - Heparin-induced thrombocytopenia: recognition, treatment and prevention. The seventh ACCP Conference on antithrombotic and thrombolytic therapy JO - Chest VL - 126 UR - https://doi.org/10.1378/chest.126.3_suppl.311S DO - 10.1378/chest.126.3_suppl.311S ID - Warkentin2004 ER - TY - JOUR AU - Acostamadiedo, J. M. AU - Iyer, U. G. AU - Owen, J. PY - 2000 DA - 2000// TI - Danaparoid sodium JO - Expert Opin Pharmacother VL - 1 UR - https://doi.org/10.1517/14656566.1.4.803 DO - 10.1517/14656566.1.4.803 ID - Acostamadiedo2000 ER - TY - CHAP AU - Schneider, K. S. PY - 2004 DA - 2004// TI - Elimination of danaparoid by means of filtration – determination of the elimination technique in saline, human albumin and human whole blood. Elimination von Danaparoid mittels Filtration – Bestimmung der Eliminationstechnik in physiologischer Kochsalzlösung, Humanalbumin und humanem Vollblut BT - PhD thesis. Medizinische Fakultät, Albert-Ludwigs-Universität, Freiburg im Breisgau ID - Schneider2004 ER - TY - JOUR AU - Hassell, K. PY - 2005 DA - 2005// TI - The management of patients with heparin-induced thrombocytopenia who require anticoagulant therapy JO - Chest VL - 127 UR - https://doi.org/10.1378/chest.127.2_suppl.1S DO - 10.1378/chest.127.2_suppl.1S ID - Hassell2005 ER - TY - JOUR AU - Lindhoff-Last, E. AU - Betz, C. AU - Bauersachs, R. PY - 2001 DA - 2001// TI - Use of a low molecular weight heparinoid (danaparoid sodium) for continuous renal replacement therapy in intensive care patients JO - Clin Appl Thromb Haemost VL - 7 UR - https://doi.org/10.1177/107602960100700409 DO - 10.1177/107602960100700409 ID - Lindhoff-Last2001 ER - TY - JOUR AU - Lo, G. K. AU - Juhl, D. AU - Warkentin, T. E. AU - Sigouin, C. S. AU - Eichler, P. AU - Greinacher, A. PY - 2006 DA - 2006// TI - Evaluation of pretest clinical score (4T's) for the diagnosis of heparin-induced thrombocytopenia in two clinical settings JO - J Thromb Haemost VL - 4 UR - https://doi.org/10.1111/j.1538-7836.2006.01787.x DO - 10.1111/j.1538-7836.2006.01787.x ID - Lo2006 ER - TY - JOUR AU - Ronco, C. AU - Bellomo, R. AU - Homel, P. AU - Brendolan, A. AU - Dan, M. AU - Piccinni, P. AU - La Greca, G. PY - 2000 DA - 2000// TI - Effects of different doses in continuous veno-venous haemofiltration on outcomes of acute renal failure: a prospective, randomised trial JO - Lancet VL - 356 UR - https://doi.org/10.1016/S0140-6736(00)02430-2 DO - 10.1016/S0140-6736(00)02430-2 ID - Ronco2000 ER - TY - JOUR AU - de Pont, A. C. AU - Oudemans-van Straaten, H. M. AU - Roozendaal, K. J. AU - Zandstra, D. F. PY - 2000 DA - 2000// TI - Nadroparin versus dalteparin anticoagulation in high-volume continuous venovenous hemofiltration: a double-blind, randomized, crossover study JO - Crit Care Med VL - 28 UR - https://doi.org/10.1097/00003246-200002000-00022 DO - 10.1097/00003246-200002000-00022 ID - de Pont2000 ER - TY - JOUR AU - Journois, D. AU - Safran, D. AU - Castelain, M. H. AU - Chanu, D. AU - Drevillon, C. AU - Barrier, G. PY - 1990 DA - 1990// TI - Comparison of the antithrombotic effects of heparin, enoxaparin and prostacycline in continuous hemofiltration. [Comparaison des effets antithrombotiques de l'héparine, l'enoxaparine et la prostacycline au cours de l'hémofiltration continue] JO - Ann Fr Anesth Reanim VL - 9 UR - https://doi.org/10.1016/S0750-7658(05)80244-8 DO - 10.1016/S0750-7658(05)80244-8 ID - Journois1990 ER - TY - JOUR AU - Joannidis, M. AU - Kountchev, J. AU - Rauchenzauner, M. AU - Schusterschitz, N. AU - Ulmer, H. AU - Mayr, A. AU - Bellmann, R. PY - 2007 DA - 2007// TI - Enoxaparin vs. unfractionated heparin for anticoagulation during continuous veno-venous hemofiltration: a randomized controlled crossover study JO - Intensive Care Med VL - 33 UR - https://doi.org/10.1007/s00134-007-0719-7 DO - 10.1007/s00134-007-0719-7 ID - Joannidis2007 ER - TY - JOUR AU - Hirsh, J. AU - Warkentin, T. E. AU - Shaughnessy, S. G. AU - Anand, S. S. AU - Halperin, J. L. AU - Raschke, R. AU - Granger, C. AU - Ohman, E. M. AU - Dalen, J. E. PY - 2001 DA - 2001// TI - Heparin and low-molecular-weight heparin: mechanisms of action, pharmacokinetics, dosing, monitoring, efficacy, and safety JO - Chest VL - 119 UR - https://doi.org/10.1378/chest.119.1_suppl.64S DO - 10.1378/chest.119.1_suppl.64S ID - Hirsh2001 ER -